Ré MI
ORCID: 0000-0002-3515-3125
· 1 paper in corpus
2019
The development of an effective amphotericin B (AmB) topical formulation to replace the systemically toxic injections currently used in cutaneous leishmaniasis (CL) treatment is challenging due to poor absorption through the skin. Aiming at…